Published Date: 08 Mar 2023
While some say this strategy's failure rate is "too high," it's one step closer to the "white grail" of a shorter 24-week formula.
Read Full NewsWechsler discusses why less frequent dosing matters to patients with severe asthma, plus VALIANT's safety profile and what's next for the field.
Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD
Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations
Adults with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive now have a second self-administration option for the complement inhibitor zilucoplan.
Three-year extension data from the phase 3 IB1001-301 trial show levacetylleucine slowed disease progression in both adults and children with Niemann-Pick disease type C.
Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era
1.
Interleukin-6 may boost prediction of obesity-related cancers
2.
Immunotherapy after surgery is good for patients with advanced cancer
3.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
4.
Sevabertinib Approved for First-Line Mutated NSCLC
5.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
1.
Emerging Therapies Using Ex Vivo Hematopoietic Tissue Engineering for Marrow Recovery
2.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
3.
Comprehensive Techniques in Hematology in Clinical Decision-Making
4.
Obesity as a major risk factor for cancer
5.
The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation